MONTVALE, N.J., March 12, 2008 (PRIME NEWSWIRE) -- In response to questions from investors, Datascope Corp. (Nasdaq:DSCP) is clarifying the meaning of the second paragraph in yesterday’s press release regarding the $240 million sale of its Patient Monitoring business, which stated that:
